Dragon Life Science Holdings Group, Inc.
NOHO · OTC
8/31/2021 | 8/31/2020 | 8/31/2019 | 8/31/2018 | |
|---|---|---|---|---|
| Market Cap | $869 | $1 | $57 | $57 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $442 | $442 | $442 |
| Enterprise Value | $869 | $442 | $499 | $499 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $24 | -$1 | -$2 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$264 | -$44 | -$140 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | -0 | -0 |
| % Growth | – | 100% | -3,646.8% | – |
| Operating Cash Flow | -$19 | -$1 | $0 | – |
| Capital Expenditures | $0 | $0 | $0 | – |
| Free Cash Flow | -$19 | -$1 | $0 | – |